Back
Revance Therapeutics Vs. GlycoMimetics Industry Stock Comparison
Sell
10
RVNC
Revance Therapeutics
Last Price:
4.26
Seasonality Move:
7.02%
Buy
71
GLYC
GlycoMimetics
Last Price:
0.40
Seasonality Move:
49.38%
Sell
10
Revance Therapeutics (RVNC)
is a Sell
Is Revance Therapeutics a Buy, Sell or Hold?
- The current Revance Therapeutics [RVNC] share price is $4.13. The Score for RVNC is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.
- RVNC is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
71
GlycoMimetics (GLYC)
is a Buy
Is GlycoMimetics a Buy, Sell or Hold?
- The current GlycoMimetics [GLYC] share price is $0.40. The Score for GLYC is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
- GLYC is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RVNC Stock Price Chart
What is Revance Therapeutics's stock price today?
-
The Revance Therapeutics share price today is $4.13
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RVNC is experiencing buying pressure, which is a positive indicator for future bullish movement.
GLYC Stock Price Chart
What is GlycoMimetics's stock price today?
-
The GlycoMimetics share price today is $0.40
The current trend is moderately bullish and GLYC is experiencing selling pressure, which indicates risk of future bearish movement.
RVNC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.28 | Sell |
Relative Strength Index (14 RSI): | 35.3 | Sell |
Chaikin Money Flow: | 4556882 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.62 - 5.92) | Sell |
Bollinger Bands (100): | (3.5 - 6.32) | Sell |
GLYC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.07 | Buy |
Relative Strength Index (14 RSI): | 65.28 | Buy |
Chaikin Money Flow: | -626089 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.14 - 0.4) | Buy |
Bollinger Bands (100): | (0.15 - 0.31) | Buy |
RVNC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.04 | Sell |
20-day SMA: | 5.28 | Sell |
50-day SMA: | 5.58 | Sell |
200-day SMA: | 4.66 | Sell |
8-day EMA: | 4.72 | Sell |
20-day EMA: | 5.14 | Sell |
50-day EMA: | 5.29 | Sell |
200-day EMA: | 6.18 | Sell |
GLYC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.4 | Sell |
20-day SMA: | 0.3 | Buy |
50-day SMA: | 0.22 | Buy |
200-day SMA: | 1.07 | Sell |
8-day EMA: | 0.39 | Buy |
20-day EMA: | 0.33 | Buy |
50-day EMA: | 0.27 | Buy |
200-day EMA: | 0.77 | Sell |
Revance Therapeutics Earnings Growth & RVNC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.38 per share, and an increase next year of $0.71 per share.
GlycoMimetics Earnings Growth & GLYC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and an increase next year of $0.01 per share.
Revance Therapeutics Technical Analysis
Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
GlycoMimetics Technical Analysis
Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |